Evaluating salbutamol's effect on wheezing in young children using video analysis
Video Assisted Study of Salbutamol Response in Viral Wheezing
This study is testing if inhaled salbutamol can help reduce wheezing in young children by comparing video recordings of their breathing before and after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 6 Months to 24 Months |
| Sex | All |
| Sponsor | University of Oulu Academic / other |
| Locations | 1 site (Oulu) |
| Trial ID | NCT06093152 on ClinicalTrials.gov |
What this trial studies
This observational study assesses the effectiveness of inhaled salbutamol in treating wheezing in children aged 6 to 24 months. Participants will receive salbutamol as per current guidelines, and their responses will be evaluated through a video-assisted crossover approach. Videos of the children will be recorded before and after treatment, and a panel of blinded pediatricians will assess the severity of wheezing. Additionally, machine vision technology will analyze the videos to compare its evaluations with those of the pediatricians.
Who should consider this trial
Good fit: Ideal candidates are children aged 6 to 24 months who are experiencing wheezing and have been prescribed salbutamol in an emergency department.
Not a fit: Patients requiring immediate resuscitation, those being transferred to ICU, or with suspected pneumonia or airway foreign body will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the effectiveness of salbutamol for wheezing in young children, potentially improving treatment protocols.
How similar studies have performed: While salbutamol is widely used, this specific video-assisted approach to evaluate its effectiveness in young children is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Wheezing * Salbutamol-treatment in emergency department prescribed Exclusion Criteria: * Need for immediate resuscitation * Immediate transfer to ICU * Suspicion of pneumonia based on the auscultation finding * Suspicion of airway foreign body
Where this trial is running
Oulu
- Department of Pediatrics, Oulu University Hospital — Oulu, Finland (Recruiting)
Study contacts
- Principal investigator: Terhi Tapiainen, Professor — University of Oulu
- Study coordinator: Ville Lindholm, MD
- Email: Ville.a.lindholm@oulu.fi
- Phone: +35883155283
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.